Literature DB >> 4116817

Effect of apomorphine on human-growth-hormone secretion.

S Lal, C E De la Vega, T L Sourkes, H G Friesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4116817     DOI： 10.1016/s0140-6736(72)93061-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Bromocriptine in the treatment of acromegaly.

Authors:  D E Bateman; W M Tunbridge
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

2.  Comparison of single and combined tests for the evaluation of plasma growth hormone secretion in normal short children.

Authors:  M C Bazán; H Domené; J J Heinrich; M Barontini; C Bergadá
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

3.  Changes in dopamine receptor sensitivity in humans after heavy alcohol intake.

Authors:  J Balldin; C Alling; C G Gottfries; G Lindstedt; G Långström
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Hypothalamic-pituitary dopaminergic function in hepatic failure in man.

Authors:  S Lal; M Oravec; A Aronoff; M E Kiely; H Guyda; S Solomon; N P Nair
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

5.  Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.

Authors:  S Lal; N P Nair; J X Thavundayil; V Tawar; R Quirion; H Guyda
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

7.  Effects of L-deprenyl on human growth hormone secretion.

Authors:  M Koulu; R Lammintausta
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

8.  Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients, with or without oral dyskinesia, withdrawn from chronic neuroleptic therapy.

Authors:  P Ettigi; N P Nair; S Lal; P Cervantes; H Guyda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-09       Impact factor: 10.154

9.  Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy.

Authors:  J Balldin; A K Granérus; G Lindstedt; K Modigh; J Wålinder
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

10.  Effect of domperidone on apomorphine-induced growth hormone secretion in normal men.

Authors:  S Lal; N P Nair; H L Iskandar; P Etienne; P L Wood; G Schwartz; H Guyda
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.